Identification and Predictors for Cardiovascular Disease Risk Equivalents Among Adults With Diabetes
Year: 2021
Type: article
Abstract: OBJECTIVE: We examined diabetes as a cardiovascular disease (CVD) risk equivalent based on diabetes severity and other CVD risk factors. RESEARCH DESIGN AND METHODS: We pooled four U.S. cohorts (Atherosclerosis Risk in Communities [ARIC], Jackson Heart Study [JHS], Multi-Ethnic Study of Atherosclerosis [MESA], and Framingham Heart Study Offspring Cohort [FHS-Offspring]) and classified subjects into groups by baseline diabetes/CVD status (positive or negative). CVD risks of the diabetes mellitus (DM)+/CVD- group versus DM-/CVD+ group were examined by diabetes severity and in subgroups of other CVD risk factors. We developed an algorithm to identify subjects with CVD risk equivalent diabetes by comparing the relative CVD risk of being DM+/CVD- versus DM-/CVD+. RESULTS: The pooled cohort included 27,730 subjects (mean age 58.5 years, 44.6% male). CVD rates per 1,000 person-years were 16.5, 33.4, 43.2, and 71.4 among those DM-/CVD-, DM+/CVD-, DM-/CVD+, and DM+/CVD+, respectively. Compared with those DM-/CVD+, CVD risks were similar or higher for those with HbA1c ≥ 7%, diabetes duration ≥10 years, or diabetes medication use, while those with less severe diabetes had lower risks. Hazard ratios (95% CI) for DM+/CVD- vs. DM-/CVD+ were 0.96 (95% CI 0.86-1.07), 0.97 (0.88-1.07), 0.96 (0.82-1.13), 1.18 (0.98-1.41), 0.93 (0.85-1.02), and 1.00 (0.89-1.13) among women and those of White race, age <55 years, and with triglycerides ≥2.26 mmol/L, hs-CRP ≥2 mg/L, and estimated glomerular filtration rate <60 mL/min/1.73 m2, respectively. In the DM+/CVD- group, 19.1% had CVD risk equivalent diabetes with a lower risk score but a higher observed CVD risk. CONCLUSIONS: Diabetes is a CVD risk equivalent in one-fifth of CVD-free adults living with diabetes. High HbA1c, long diabetes duration, and diabetes medication use were predictors of CVD risk equivalence. Diabetes is a CVD risk equivalent for women, white people, and those of younger age or with higher triglycerides or hs-CRP or reduced kidney function.
Source: Diabetes Care
DOI: 10.2337/dc21-0431
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: diabetes mellitus, cardiovascular risk, diabetes severity, HbA1c, diabetes duration, diabetes medication use, cardiovascular risk factors, risk prediction algorithm, cardiovascular events, cardiovascular mortality, cardiovascular hospitalization, cardiovascular risk score, triglycerides, high-sensitivity C-reactive protein, estimated glomerular filtration rate, sex differences, racial differences, adults with diabetes
Open Access status: green
Funders: U.S. Department of Health and Human Services, Amgen, Jackson State University, Amarin Corporation, Mississippi State Department of Health, Novo Nordisk, National Institutes of Health, University of California, Irvine, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences, National Institute on Minority Health and Health Disparities
Awards: G1114307781, G1261793039, MESA, G1276754516, G1294553593, G1446319095, G1516086731, G1522144118, G1522370804, G1540916838, G1558725192, G1640378483, Research and Mentoring in the Clinical Epidemiology of Cardiovascular Disease and Type 2 Diabetes, G1730035482, G1730507467, G1740741465, G17630474, G1788514665, G1823732541, Wake Forest Clinical and Translational Science Award, G1851406594, G1983464145, G2095942735, G2144938473, G2221742881, G22458031, G2262505034, G2415573643, G265762973, G2726417417, G2779429302, G2809357584, MESA, G2837638605, G291913881, G3057025668, G3093995152, G3161396180, G3252259982, G350245564, G3581052147, G3595232572, G3667269547, G3744596180, MESA, G3973572274, G3990748671, G4036023366, G410925890, TITLE: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), G4309390892, G4401650913, G4439124393, G4597579782, G4711807797, G4790942633, OPTION 3. 4/1/2014 - 3/31/2015. MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - READING CENTER, NHLBI, MESA, G4976486911, G4986157935, SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-ULTRASOUND, G5289537304, G5352314984, G5653954166, G5654179670, G5729620095, G6156766399, Institute for Clinical and Translational Research, MESA, G66341962, G6739173425, G6837735701, G6856766826, G7091571603, G710893387, MESA, G78770644, G7924587209, G805458286, Clinical and Translational Science Award, G8145863542, G818308888, G883699098, G89699440, G9000004549, G9000004784, G9000017360, G9000019818, G9000025517, G9000063950
OpenAlex ID: W3191438335
